658 related articles for article (PubMed ID: 15569773)
1. Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophilic leukemia RBL-2H3.
Okoshi Y; Tahara-Hanaoka S; Nakahashi C; Honda S; Miyamoto A; Kojima H; Nagasawa T; Shibuya K; Shibuya A
Int Immunol; 2005 Jan; 17(1):65-72. PubMed ID: 15569773
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Fc gamma receptors on rat mucosal mast cells using a mutant Fc epsilon RI-deficient rat basophilic leukemia line.
Bocek P; Dráberová L; Dráber P; Pecht I
Eur J Immunol; 1995 Oct; 25(10):2948-55. PubMed ID: 7589096
[TBL] [Abstract][Full Text] [Related]
3. Review: Diagnostic and therapeutic applications of rat basophilic leukemia cells.
Rashid A; Sadroddiny E; Ye HT; Vratimos A; Sabban S; Carey E; Helm B
Mol Immunol; 2012 Oct; 52(3-4):224-8. PubMed ID: 22750069
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking of Thy-1 glycoproteins or high-affinity IgE receptors induces mast cell activation via different mechanisms.
Dráberová L; Dráber P
Immunology; 1993 Sep; 80(1):103-9. PubMed ID: 7902332
[TBL] [Abstract][Full Text] [Related]
5. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
6. Src family-selective tyrosine kinase inhibitor, PP1, inhibits both Fc epsilonRI- and Thy-1-mediated activation of rat basophilic leukemia cells.
Amoui M; Dráber P; Dráberová L
Eur J Immunol; 1997 Aug; 27(8):1881-6. PubMed ID: 9295022
[TBL] [Abstract][Full Text] [Related]
7. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
8. Tryptanthrin inhibits Th2 development, and IgE-mediated degranulation and IL-4 production by rat basophilic leukemia RBL-2H3 cells.
Iwaki K; Ohashi E; Arai N; Kohno K; Ushio S; Taniguchi M; Fukuda S
J Ethnopharmacol; 2011 Mar; 134(2):450-9. PubMed ID: 21216280
[TBL] [Abstract][Full Text] [Related]
9. Bifidobacterium suppresses IgE-mediated degranulation of rat basophilic leukemia (RBL-2H3) cells.
Harata G; He F; Takahashi K; Hosono A; Kawase M; Kubota A; Hiramatsu M; Kaminogawa S
Microbiol Immunol; 2010; 54(1):54-7. PubMed ID: 20055943
[TBL] [Abstract][Full Text] [Related]
10. PICOT, protein kinase C theta-interacting protein, is a novel regulator of FcepsilonRI-mediated mast cell activation.
Kato N; Motohashi S; Okada T; Ozawa T; Mashima K
Cell Immunol; 2008 Jan; 251(1):62-7. PubMed ID: 18479680
[TBL] [Abstract][Full Text] [Related]
11. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
Gentile DA; Skoner DP
Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
[TBL] [Abstract][Full Text] [Related]
12. Gab2 antisense oligonucleotide blocks rat basophilic leukemic cell functions.
Chan JH; Liao W; Lau HY; Wong WS
Int Immunopharmacol; 2007 Jul; 7(7):937-44. PubMed ID: 17499196
[TBL] [Abstract][Full Text] [Related]
13. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis.
Tanaka A; Tanaka T; Suzuki H; Ishii K; Kameyoshi Y; Hide M
Exp Dermatol; 2006 Apr; 15(4):283-90. PubMed ID: 16512875
[TBL] [Abstract][Full Text] [Related]
14. Use of Engineered Nanoparticles (ENPs) for the Study of High-Affinity IgE FcεRI Receptor Engagement and Rat Basophilic Leukemia (RBL) Cell Degranulation.
Alelwani W; Alharbi RA; Wan D; Vllasaliu D; Falcone FH; Stolnik S
Methods Mol Biol; 2020; 2163():171-180. PubMed ID: 32766975
[TBL] [Abstract][Full Text] [Related]
15. The leukocyte receptor CD84 inhibits Fc epsilon RI-mediated signaling through homophilic interaction in transfected RBL-2H3 cells.
Oliver-Vila I; Saborit-Villarroya I; Engel P; Martin M
Mol Immunol; 2008 Apr; 45(8):2138-49. PubMed ID: 18243321
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IgE-mediated phosphorylation of FcepsilonRIgamma protein by antiallergic drugs in rat basophilic leukemia (RBL-2H3) cells: a novel action of antiallergic drugs.
Hanashiro K; Sunagawa M; Nakasone T; Nakamura M; Kosugi T
Int Immunopharmacol; 2007 Jul; 7(7):994-1002. PubMed ID: 17499203
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody that inhibits secretion from rat basophilic leukemia cells and binds to a novel membrane component.
Ortega Soto E; Pecht I
J Immunol; 1988 Dec; 141(12):4324-32. PubMed ID: 2974058
[TBL] [Abstract][Full Text] [Related]
18. Requirements for effective IgE cross-linking on mast cells and basophils.
Knol EF
Mol Nutr Food Res; 2006 Jul; 50(7):620-4. PubMed ID: 16764017
[TBL] [Abstract][Full Text] [Related]
19. A novel insight to the functional role of Stathmin 1 in IgE-mediated activation of RBL-2H3 cells.
Sadroddiny E; Moir AJ; A Helm B
Iran J Allergy Asthma Immunol; 2011 Jun; 10(2):73-80. PubMed ID: 21625015
[TBL] [Abstract][Full Text] [Related]
20. Role of CC chemokines and their receptors in multiple aspects of mast cell biology: comparative protein profiling of FcepsilonRI- and/or CCR1-engaged mast cells using protein chip technology.
Toda M; Nakamura T; Ohbayashi M; Ikeda Y; Dawson M; Richardson RM; Alban A; Leed B; Miyazaki D; Ono SJ
Novartis Found Symp; 2005; 271():131-40; discussion 140-51. PubMed ID: 16605132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
